12 maggio 2021 16:52
Fonte: Adnkronos
#salute-e-benessere
Product recently cleared in EU as Class III medical device
BALERNA, Switzerland, May 12, 2021 /PRNewswire/ APR Applied Pharma Research s.a. (APR), a leader in the development of pharmaceutical drug delivery technologies and systems and innovative products derived thereof, today announced the start of a pivotal clinical trial to assess the efficacy of its product temporarily codenamed APR-AOS2020, a Class III medical device, in the treatment of COVID-19 patients showing mild symptoms. The study is being conducted by the Hygiene Unit of IRCCS Policlinico San Martino Hospital in Genoa, Italy and coordinated by Prof. Giancarlo Icardi as lead investigator. The study is planned to enroll a total of 57 COVID-19 patients who show mild symptoms of the disease and is evaluating the efficacy and safety of the spray product in reducing viral load in the upper respiratory airways in recently infected individuals. Results, when availa
From the mayor s desk: Stratford mayor Neil Volzke discusses the local government review
4 May, 2021 08:47 AM
3 minutes to read
By: Neil Volzke, Stratford District Mayor
The Government has initiated the first independent review of the local government sector in three decades that will focus on how local democracy and local governance need to evolve over the next three decades.
The review panel will be made up of five people and is expected to report back in April 2023.
The panel is to explore local government s future in terms of roles, functions, partnerships, representation, governance, funding and financing. The review is also tasked with honouring the Treaty of Waitangi and its principles.